Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
4.19Prev. Close
4.10Volume
1,24,990Total traded value
0.05 CrUpper Circuit
4.92Lower Circuit
3.28Fundamentals
| Market Cap | ₹31Cr |
| ROE | -6.74% |
| P/E Ratio(TTM) | -24.12 |
| EPS(TTM) | -0.17 |
| P/B Ratio | 3.10 |
| Dividend Yield | 0.00% |
| Industry P/E | 68.71 |
| Book Value | 1.32 |
| Debt to Equity | 1.45 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Transgene Biotek
Transgene Biotek is a bio-pharmaceutical company focused on researching and developing innovative biologic molecules and creating unique oral or nasal drug delivery formulations. The company's core philosophy centers on creating long-term shareholder value through responsible decision-making and adhering to high ethical standards. Its technology platform has successfully demonstrated exceptional bio-availability, a key indicator of success for new drug delivery methods.;
| Parent Organisation | Transgene Biotek Limited |
| Managing Director | Dr. K. Koteswara Rao |
| BSE Symbol | 526139 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JSW Infrastructure | NA (0.00%) | 38.67 | ||
| Max Financial Services | NA (0.00%) | 156.98 | ||
| Central Depository Services (India) | NA (0.00%) | 68.32 | ||
| Aegis Vopak Terminals | NA (0.00%) | 203.96 |